Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Prevalence of Nonmelanoma Skin Cancers High in VHA

Dermatol Surg; ePub 2016 Jul 25; Yoon, Phibbs, et al

There is high prevalence of keratinocyte carcinoma (KC) and actinic keratosis (AK), and considerable spending to treat these conditions, in the Veterans Health Administration (VHA), a recent study found. Researchers conducted a cross-sectional analysis of veterans diagnosed with KC or AK during fiscal year 2012, using administrative data on outpatient encounters and prescription drugs provided by or paid for by the VHA. They found:

• In 2012, there were 49,229 veterans with basal cell carcinoma, 26,310 veterans with squamous cell carcinoma, and 8,050 veterans with unspecified invasive KC.

• There were also 197,041 veterans with AK and 6,388 veterans with KC-related diagnoses.

• The VHA spent $356 million on KC and AK outpatient treatment for procedures, prescription drugs, and other dermatologic care during fiscal year 2012.

Citation: Yoon J, Phibbs CS, Chow A, Pomerantz H, Weinstock MA. Costs of keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis treatment in the Veterans Health Administration. [Published online ahead of print July 25, 2016]. Dermatol Surg. doi:10.1097/DSS.0000000000000820.

This Week's Must Reads

Link Between AD and Autoimmune Disorders, J Am Acad Dermatol; ePub 2018 Oct 1; Narla, et al

Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al

Prevalence of Acne Vulgaris Among Patients with HS, J Am Acad Dermatol; ePub 2018 Oct 1; Wertenteil, et al

Skin Disease Epidemiology in a Diverse Population, J Drugs Dermatol; 2018 Oct; Gaulding, et al

Psoriasis Treatment Receives Tentative FDA Approval, Bausch Heath news release; 2018 Oct 8

Must Reads in Melanoma

Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al

Follicular Involvement Frequent in Lentigo Maligna, J Am Acad Dermatol; ePub 2018 Sep 26; Connolly, et al

Sentinel Lymph Node Positivity Markers in Melanoma, J Am Acad Dermatol; ePub 2018 Sep 18; Conic, et al

Nevus Development Trajectory from Age 3 to 16 Years, JAMA Dermatology; ePub 2018 Sep 12; Asdigian, et al

Mohs Surgery Effective for Invasive Melanomas, Dermatolog Surg; ePub 2018 Sep 7; Degesys, et al